<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on Eli Lilly And Company</title><link href="http://factsaboutmenopause.com/topic/eli-lilly-and-company" rel="alternate"></link><id>http://factsaboutmenopause.com/topic/eli-lilly-and-company</id><updated>2010-08-25T14:14:24Z</updated><entry><title>Lilly will not seek FDA approval for arzoxifene</title><link href="http://factsaboutmenopause.com/lilly-seek-fda-approval-arzoxifene-636539a" rel="alternate"></link><updated>2010-08-25T14:14:24Z</updated><author><name>AP Features</name></author><id>tag:factsaboutmenopause.com,2010-08-25:/lilly-seek-fda-approval-arzoxifene-636539a</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="Eli Lilly and Company" href="/topic/Eli+Lilly+and+Company" &gt;Eli Lilly&lt;/a&gt; &amp;amp;amp;amp; Co. said Tuesday it will not seek &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; approval for its developing postmenopausal osteoporosis drug because of certain study results and safety concerns. The company said the drug met its late-stage study goals of reducing the risk of vertebral fracture and invasive breast cancer, ...</summary><category term="Company Activities and Information"></category><category term="Corporate Reporting"></category><category term="Earnings and Losses"></category><category term="Financial Markets"></category><category term="Stock Performance"></category><category term="Menopause"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Women's Health"></category><category term="John Lechleiter"></category></entry><entry><title>Prescription Drugs Heist</title><link href="http://factsaboutmenopause.com/photo/prescription-drugs-heist-2197296p" rel="alternate"></link><updated>2010-03-26T16:41:28Z</updated><author><name>AP News</name></author><id>tag:factsaboutmenopause.com,2010-03-26:/photo/prescription-drugs-heist-2197296p</id><summary type="html">The &lt;a title="Eli Lilly and Company" href="/topic/Eli+Lilly+and+Company" &gt;Eli Lilly&lt;/a&gt; warehouse is seen here in Enfield, &lt;a title="Connecticut" href="/topic/Connecticut" &gt;Conn.&lt;/a&gt;, Tuesday, March 16, 2010.  Authorities say tens of millions of dollars worth of prescription drugs have been stolen in a brazen, well-planned heist at a pharmaceutical company's regional warehouse in Connecticut.  (AP Photo/Journal Inquirer/Leslloyd F. Alleyne) MANDATORY CREDIT
&lt;div id="copyright"&gt;&lt;div&gt;
        Copy...</summary><category term="Crime"></category><category term="Grand Larceny"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category></entry><entry><title>Eli Lilly Reorganization</title><link href="http://factsaboutmenopause.com/photo/eli-lilly-reorganization-1736502p" rel="alternate"></link><updated>2010-04-01T19:34:49Z</updated><author><name>AP News</name></author><id>tag:factsaboutmenopause.com,2010-04-01:/photo/eli-lilly-reorganization-1736502p</id><summary type="html">FILE - In this Jan 25, 2006 file photo, The &lt;a title="Eli Lilly and Company" href="/topic/Eli+Lilly+and+Company" &gt;Eli Lilly and Company&lt;/a&gt; headquarters in pictured in &lt;a title="Indianapolis" href="/topic/Indianapolis" &gt;Indianapolis&lt;/a&gt;. Drugmaker Eli Lilly &amp;amp; Co. said Monday, Sept. 14, 2009, that it will eliminate 5,500 jobs, or nearly 14 percent of its staff, and reorganize into five business units in order to slash costs and speed up development of potential new drugs. (AP Photo/Darron Cum...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category></entry></feed>